Colombo AR, Hav M, Singh M, Xu A, Gamboa A, Lemos T, Gerdtsson E, Chen D, Houldsworth J, Shaknovich R, et al. Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma. Blood Adv. 2022. 23. 6. 4675-4690
Bourne CM, Mun SS, Dao T, Aretz ZEH, Molvi Z, Gejman RS, Daman A, Takata K, Steidl C, Klatt MG, et al. Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. Blood Adv. 2022. 26. 6. 4107-4121
Takata K, Steidl C. Genetic mechanism for the loss of PRAME in B cell lymphomas. Reply. J Clin Invest. 2022. 132. 14. e161979
Takata K, Chong LC, Ennishi D, Aoki T, Li MY, Thakur A, Healy S, Viganò E, Dao T, Kwon D, et al. Tumor associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B-cell lymphoma. J Clin Invest. 2022. e145343
Daniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, Lauren Chong, Bryan Fraser, Jutta Zeisler, Tomoko Miyata-Takata, Helen Merkens, Julie Rousseau, Tomohiro Aoki, et al. Targeting refractory mantle cell lymphoma for imaging and therapy using C-X-C chemokine receptor type 4 radioligands. Clinical Cancer Research. 2022. 28. 8. clincanres.3284.2021-clincanres.3284.2021